Health ❯ Cancer ❯ Pancreatic Cancer ❯ Treatment

Clinical Trials

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

An FDA early-access program has triggered heavy demand that is straining cancer centers.

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

Ben Sasse Details Tumor Shrinkage and Harsh Side Effects in Frank Cancer Interview